Result: Risk Minimisation Materials for medicines starting with the letter P

Paracetamol

Actavis UK Ltd

Paracetamol 10mg/ml Solution for Infusion training poster

Further copies of the Dosing Calculator can be obtained from our Medical Information Department at 01271 385257 or e-mail: Medinfo@accord-healthcare.com 

For Healthcare Professionals

PecFent

Kyowa Kirin Ltd

PecFent Healthcare Professional Guide

PecFent (fentanyl citrate) nasal spray - Important risk minimisation information for healthcare professionals

For Healthcare Professionals

PecFent Patient and Carer guide

PecFent (fentanyl citrate) nasal spray - Important risk minimisation information for patients and their carers

Penthrox

Galen Limited

Penthrox Administration Checklist-HCP use

Penthrox Administration Checklist-HCP use Further copies of the educational materials and training on the administration of Penthrox are available from Galen on request (tel 028 38334974 or email customer.services@galen-pharma.com).

For Healthcare Professionals

Penthrox Administration Guide-HCP use

Penthrox Administration Guide-HCP use Further copies of the educational materials and training on the administration of Penthrox are available from Galen on request (tel 028 38334974 or email customer.services@galen-pharma.com).

For Healthcare Professionals

Penthrox Patient Alert Card-Patient Use

Penthrox Patient Alert Card-Patient Use

Perfalgan

Bristol-Myers Squibb Pharmaceuticals limited

Perfalgan (paracetamol) Poster

Perfalgan (paracetamol) has risk minimisation materials, a Dosing Tool and a Poster. Hard copies of the Perfalgan Dosing Tool and Poster can be obtained from Bristol-Myers Squibb Medical Information (telephone: 0800 731 1736; e-mail: medical.information@bms.com).

For Healthcare Professionals

Peyona

Chiesi Limited

Peyona (caffeine citrate) 20 mg/ml Solution for Infusion and Oral Solution Laminated Card

Before using Peyona (caffeine citrate) 20 mg/ml either intravenously or orally, in addition to reading the Summary of Product Characteristics, please check the following points:

For Healthcare Professionals

Peyona (caffeine citrate) 20mg/ml solution for infusion and oral solution

Information on the safe use of Peyona (caffeine citrate) 20mg/ml solution for infusion and oral solution

For Healthcare Professionals

Pharmalgen bee venom

ALK-Abello Ltd

Change of licence to remove Pharmalgen Initial packs

Dear Healthcare Professional Letter to aid with the transition from using Pharmalgen Initial kits to diluting the new Pharmalgen kit

For Healthcare Professionals

PASS form

Post Authorisation Safety Study form to aid with the transition from using Pharmalgen Initial kits to diluting the new Pharmalgen kit

For Healthcare Professionals

Serial Dilutions Chart

Serial Dilutions chart to aid with the transition from using Pharmalgen Initial kits to diluting the new Pharmalgen kit

For Healthcare Professionals

Pharmalgen wasp venom

ALK-Abello Ltd

Change of licence to remove Pharmalgen Initial packs

Dear Healthcare Professional Letter to aid with the transition from using Pharmalgen Initial kits to diluting the new Pharmalgen kit

For Healthcare Professionals

PASS form

Post Authorisation Safety Study form to aid with the transition from using Pharmalgen Initial kits to diluting the new Pharmalgen kit

For Healthcare Professionals

Serial Dilutions Chart

Serial Dilutions chart to aid with the transition from using Pharmalgen Initial kits to diluting the new Pharmalgen kit

For Healthcare Professionals

Pioglitazone

Accord Healthcare Limited

Pioglitazone Accord Educational Materials on risk of bladder cancer and heart failure

Educational Materials on risk of bladder cancer and heart failure with pioglitazone.

For Healthcare Professionals

Portrazza

Eli Lilly and Company Limited

Portrazza (necitumumab) - important risk minimisation information for doctors

Important safety information on the key conditions for the safe use of necitumumab.

For Healthcare Professionals

Powergel

A. Menarini Farmaceutica Internazionale SRL

Pradaxa

Boehringer Ingelheim Limited

Pradaxa (dabigatran etexilate) Patient Alert Card

Every patient prescribed Pradaxa will receive a Patient Alert Card in the medication pack. As the card contains important information the patient should be instructed to carry the patient alert card at all times and present it when seeing a health care professional. The patient should be counselled about the need for compliance and signs of bleeding and when to seek medical attention.

Pradaxa (dabigatran etexilate) Prescriber guide for primary prevention of venous thromboembolic events (VTE) following elective hip or knee replacement surgery

This risk minimisation material provides recommendations for the use of Pradaxa in VTE (orthopaedic) in order to minimise the risk of bleeding. Please ensure you are familiar with this material as it contains important safety information. In particular it is aimed at increasing awareness about the potential risk of bleeding during treatment with Pradaxa and providing guidance on how to manage that risk. For hard copies please contact our medical information department at 01344 424600 or email: medinfo@bra.boehringer-ingelheim.com

For Healthcare Professionals

Pradaxa (dabigatran etexilate) Prescriber Guide for stroke prevention in non-valvular atrial fibrillation (NVAF) and for the treatment and secondary prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE)

This risk minimisation material provides recommendations for the use of Pradaxa in NVAF and DVT/PE in order to minimise the risk of bleeding. Please ensure that you are familiar with this material as it contains important safety information. In particular it is aimed at increasing awareness about the potential risk of bleeding during treatment with Pradaxa and providing guidance on how to manage that risk. For hard copies please contact our medical information department at 01344 424600 or email: medinfo@bra.boehringer-ingelheim.com

For Healthcare Professionals

Prenoxad

Martindale Pharma

Direct Communication to Healthcare Professionals. Reformulation of Prenoxad injection 1mg/ml

Direct Communication to Healthcare Professionals. Prenoxad Injection (naloxone hydrochloride): reformulation to correct historic error in the expression of the strength; no changes in use or dosing schedule.

For Healthcare Professionals

Direct Communication to Non-HCP, Wholesalers and purchasing groups. Reformulation of Prenoxad 1mg/ml

Direct Communication to Non-medical practitioners involved in treatment services, Wholesalers and other direct purchasing groups. Prenoxad Injection (naloxone hydrochloride): reformulation to correct historic error in the expression of the strength; no changes in use or dosing schedule.

For Healthcare Professionals

Direct Communication to Non-HCPs, Wholesalers and purchasing groups. Prenoxad 0.91 mg/ml. Correction made to the Prenoxad Injection labelling.

Direct Communication to Non-medical practitioners involved in treatment services, Wholesalers and other direct purchasing groups on the correction made to the Prenoxad Injection following a historic error in the drug product labelling. Naloxone Hydrochloride, Prenoxad Injection, label correction

For Healthcare Professionals

Direct communication to patient, carers and community workers who have been supplied with Prenoxad Injection. Prenoxad 0.91 mg/ml

Direct communication to patient, carers and community workers who have been supplied with Prenoxad Injection Information regarding correcting the historic error on Prenoxad labelling.

Direct Communication to patients, carers and community workers who have been supplied with Prenoxad Injection. Reformulation of Prenoxad injection 1mg/ml

Direct Communication to patients, carers and community workers who have been supplied with Prenoxad Injection. Information regarding correcting an historic error in the Prenoxad formulation.

Direct Healthcare Professional Communication. Prenoxad 0.91 mg/ml. Correction made to the Prenoxad Injection labelling.

Direct Healthcare Professional Communication on the correction made to the Prenoxad Injection following a historic error in the drug product labelling. Naloxone Hydrochloride, Prenoxad Injection, label correction

For Healthcare Professionals

Priligy

A. Menarini Farmaceutica Internazionale SRL

Pro-Epanutin

Pfizer Limited

Pro-Epanutin in Status Epilepticus. Dosing Aid For Adults Only

This dosing aid is designed to help you administer a loading dose of fosphenytoin. Use the equations and/or consult the dosing table to determine the appropriate dosing information based on patient weight.

For Healthcare Professionals

Pro-Epanutin in Status Epilepticus. Dosing Aid For Children 5 years and older

For Children 5 years and older. This dosing aid is designed to help you administer a loading dose of fosphenytoin. Use the equations and/or consult the dosing table to determine the appropriate dosing information based on patient weight.

For Healthcare Professionals

Prolia

Amgen Ltd

Prolia patient reminder card

This reminder card contains important safety information that patients need to be aware of before and during treatment with denosumab (Prolia), which is used to treat osteoporosis and bone loss. A side effect called osteonecrosis of the jaw (ONJ) (bone damage in the jaw) has been reported rarely (may affect up to 1 in 1,000 people) in patients receiving Prolia for osteoporosis. ONJ can also occur after stopping treatment. It is important to try to prevent ONJ developing as it may be a painful condition that can be difficult to treat. In order to reduce the risk of developing ONJ, there are some precautions patients should take. To request a copy of the patient card, please contact Amgen Medical Information on +44 (0) 1223 436441

Protelos

Servier Laboratories Limited

Patient Alert Card

For Healthcare Professionals

Prescriber Guide and Check-list

For Healthcare Professionals